IL6 and bacterial infectious disease: These results and the significant differences found in the peak concentrations of CRP (p = 0.019) and IL-6 (0.014) between patients with impaired and normal DLCO suggest that lung damage is a complex process, determined not only by the direct effect of SARS-CoV-2, but also by immune system function and probable secondary bacterial infections in patients with severe and critical disease.